Industry seeks trust and louder voice in HTA evolution, says Efpia
This article was originally published in SRA
The pharmaceutical industry has, so far, had only narrow input into a pilot project that was launched by the European Network for Health Technology Assessment (EUnetHTA) to evaluate how to improve and accelerate relative effectiveness assessments for drugs1.
You may also be interested in...
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.